Selective benefit of donepezil on oral naming in Alzheimer's disease in men compared to women

CNS Spectrums

Volumn 14, Issue 4, 2009, Pages 175-176

  Davis, Meghan L ^a   Barrett, Anna M ^a,b  

^a KESSLER FOUNDATION   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PLACEBO; TACRINE; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; BOSTON NAMING TEST; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG EFFICACY; HOPKINS VERBAL LEARNING TEST; HUMAN; LETTER; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SEX DIFFERENCE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; MALE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DEVELOPMENT;

ALZHEIMER DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDANS; MALE; NOOTROPIC AGENTS; PIPERIDINES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SEX CHARACTERISTICS;

EID: 66849117074     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900020174     Document Type: Letter

References (10)

1. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 1998;50:136-145.
2. Barrett AM, Eslinger PJ, Ballentine NH, et al. Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects. Neurology. 2005;64:693-699.
3. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
4. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Media, Penn: Williams & Wilkins; 1983.
5. Brandt, J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5:125-142.
6. Takeda A, Loveman A, Clegg J, et al. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21:17-28.
7. Haywood WM, Mukaetova-Ladinska, EB. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's Disease. Am J Geriatr Pharmacother. 2006;4:273-286.
8. MacGowan SH, Wilcock GK, Scott M. Effect of sex and apolipoprotein E genotype on response to anthicholinesterase therapy in Alzheimer's disease. Int J Geriatr Psychiatry. 1998;13:625-630.
9. King KA, Hough MS, Walker MM, et al. Mild traumatic brain injury: Effects on naming in word retrieval and discourse. Brain Inj. 2006;20:725-732.
10. Klein, RB, Martin, LA. Can drug therapies improve language functions of individuals with aphasia? A review of the evidence. Semin Speech Lang. 2004;25:193-220.